My Companies

I'm proud to have been involved in founding several great and innovative MedTech startups, each addressing a critical unmet need in Cardiology.

Echopoint Logo v2 c alpha.png

Echopoint Medical Ltd was founded in 2018 as a spin out from UCL with funding from UCLTF and Parkwalk Advisors. Echopoint is developing transformative interventional tools to address critical problems in coronary intervention, including the iKOr system and microcatheter.

Rhythm AI was founded in 2018 as a spin out from Barts Health NHS Trust. It is developing revolutionary new methods of targeting areas for more efficient and effective ablation of atrial fibrillation. 

RhythmAILogo.png
Epicardio_logo_trg.png

Epicardio provides the world's first, web delivered, whole heart electrical simulation for teaching and training. It is in use in medical schools and institutions across the globe to bring a real understanding of arrhythmia to trainees worldwide.

Dr Finlay works with the world's greatest cardiac medical device companies, and has received research funding, grants, travel support, educational support, lecture and consultancy fees from Biosense Webster (J&J) ltd, Abbott Ltd, Medtronic Ltd, Biotronik GmBH amongst others.